1 - 10 of 422 Results
Condition Status ˆ Requirements ˇ Location Near You ˇ
Human Immunodeficiency Virus (HIV)
Completed
2-18

To find a center near you, please provide a Country or Postal Code.

APV 20003-A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
APV 20003-A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
Human Immunodeficiency Virus (HIV)
Completed

No Limit

To find a center near you, please provide a Country or Postal Code.

APV10006-A Pivotal, Phase I, Single-dose, Open-label, Randomized, Two-way Crossover Study to Assess the Bioequivalence of 2x700mg GW433908 Oral Film-coated Tablets to 3x465mg GW433908 Oral Film-coated Tablets in Healthy Adult Subjects
APV10006-A Pivotal, Phase I, Single-dose, Open-label, Randomized, Two-way Crossover Study to Assess the Bioequivalence of 2x700mg GW433908 Oral Film-coated Tablets to 3x465mg GW433908 Oral Film-coated Tablets in Healthy Adult Subjects
Human Immunodeficiency Virus (HIV)
Completed

No Limit

To find a center near you, please provide a Country or Postal Code.

APV10009-A Phase I, Randomized Study to Assess the Effect of Efavirenz 600mg QD on Steady-State Plasma Total Amprenavir and Ritonavir PK Following Coadministration with GW433908 1395mg QD + Ritonavir 200mg QD or GW433908 1395mg QD + Ritonavir 300mg QD for 14 Days as Compared to GW433908 1395mg QD + Riton ...
APV10009-A Phase I, Randomized Study to Assess the Effect of Efavirenz 600mg QD on Steady-State Plasma Total Amprenavir and Ritonavir PK Following Coadministration with GW433908 1395mg QD + Ritonavir 200mg QD or GW433908 1395mg QD + Ritonavir 300mg QD for 14 Days as Compared to GW433908 1395mg QD + Riton ...
Human Immunodeficiency Virus (HIV)
Completed

No Limit

To find a center near you, please provide a Country or Postal Code.

APV10011-A Phase I, Open, Randomized, Balanced, Incomplete Crossover Drug-Drug Interaction Study to Assess the Steady-State Plasma Amprenavir and Lopinavir Pharmacokinetics following Administration of Lopinavir 533mg/Ritonavir 133mg BID + GW433908 1400mg BID, GW433908 700mg BID + Ritonavir 100mg BID, or…
APV10011-A Phase I, Open, Randomized, Balanced, Incomplete Crossover Drug-Drug Interaction Study to Assess the Steady-State Plasma Amprenavir and Lopinavir Pharmacokinetics following Administration of Lopinavir 533mg/Ritonavir 133mg BID + GW433908 1400mg BID, GW433908 700mg BID + Ritonavir 100mg BID, or…
Human Immunodeficiency Virus (HIV)
Completed

No Limit

To find a center near you, please provide a Country or Postal Code.

APV10013-A Phase I, Randomized, Open Label, Three Period, Single Sequence, Steady State, Drug-Drug Interaction Study between Atorvastatin 10mg QD and GW433908 1400mg BID and between Atorvastatin 10mg QD and GW433908 700mg BID + Ritonavir 100mg BID in Healthy Adult Subjects
APV10013-A Phase I, Randomized, Open Label, Three Period, Single Sequence, Steady State, Drug-Drug Interaction Study between Atorvastatin 10mg QD and GW433908 1400mg BID and between Atorvastatin 10mg QD and GW433908 700mg BID + Ritonavir 100mg BID in Healthy Adult Subjects
Human Immunodeficiency Virus (HIV)
Completed

No Limit

To find a center near you, please provide a Country or Postal Code.

APV10015-A Pivotal, Phase I, Single-dose, Open-label, Randomized, Three Period, Balanced Crossover Study to Assess the Bioequivalence of GW433908 Oral Film-coated 700mg Tablet Formulations in Healthy Adult Subjects
APV10015-A Pivotal, Phase I, Single-dose, Open-label, Randomized, Three Period, Balanced Crossover Study to Assess the Bioequivalence of GW433908 Oral Film-coated 700mg Tablet Formulations in Healthy Adult Subjects
Human Immunodeficiency Virus (HIV)
Completed

No Limit

To find a center near you, please provide a Country or Postal Code.

APV10016-A Pivotal, Phase I, Single-dose, Open-label, Randomized, Four Period, Balanced Crossover Study to Assess the Relative Bioavailability of the GW433908 Oral Suspension and Oral Film-coated 700mg Tablet Formulations and the Effect of Food on the Bioavailability of These Formulations in Healthy Adul ...
APV10016-A Pivotal, Phase I, Single-dose, Open-label, Randomized, Four Period, Balanced Crossover Study to Assess the Relative Bioavailability of the GW433908 Oral Suspension and Oral Film-coated 700mg Tablet Formulations and the Effect of Food on the Bioavailability of These Formulations in Healthy Adul ...
Human Immunodeficiency Virus (HIV)
Active, not recruiting
4-2

To find a center near you, please provide a Country or Postal Code.

APV20002-Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
APV20002-Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
Human Immunodeficiency Virus (HIV)
Active, not recruiting
2-18

To find a center near you, please provide a Country or Postal Code.

A4001031-An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children
A4001031-An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children
Human Immunodeficiency Virus (HIV)
Completed

No Limit

To find a center near you, please provide a Country or Postal Code.

CNA10905-An Open-Label, Single-Arm, Pharmacokinetic Study of Abacavir and its Intracellular Anabolite Carbovir Triphosphate Following Chronic Administration of an Abacavir 300mg BID Containing Regimen (Ziagen or Trizivir) in HIV Infected Patients
CNA10905-An Open-Label, Single-Arm, Pharmacokinetic Study of Abacavir and its Intracellular Anabolite Carbovir Triphosphate Following Chronic Administration of an Abacavir 300mg BID Containing Regimen (Ziagen or Trizivir) in HIV Infected Patients